4
Changes in Ownership
Tonix Pharmaceuticals Holding Corp. Filed Acc 0001387131-22-002105
Options or other derivatives
- Chief Executive Officer acquired 20,000,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
LEDERMAN SETH · Chief Executive Officer
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-15 | Grant or award : show line 1 in the form Stock Option | +5,000,000 | 5,000,000 | D |
| 2022-02-15 | Grant or award : show line 2 in the form Stock Option | +5,000,000 | 5,000,000 | D |
| 2022-02-15 | Grant or award : show line 3 in the form Stock Option | +5,000,000 | 5,000,000 | D |
| 2022-02-15 | Grant or award : show line 4 in the form Stock Option | +5,000,000 | 5,000,000 | D |
Loading xslF345X03/lederman-form4_021522.xml…